Bay, S. B. Et Al. 2019. Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency. MELANOMA RESEARCH , vol.29, no.1 , 99-101.

Bay, S. B., Kebudi, R., & Zulfikar, B., (2019). Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency. MELANOMA RESEARCH , vol.29, no.1, 99-101.

Bay, Sema, Rejin KEBUDİ, And Osman Bülent ZÜLFİKAR. "Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency," MELANOMA RESEARCH , vol.29, no.1, 99-101, 2019

Bay, Sema B. Et Al. "Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency." MELANOMA RESEARCH , vol.29, no.1, pp.99-101, 2019

Bay, S. B. Kebudi, R. And Zulfikar, B. (2019) . "Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency." MELANOMA RESEARCH , vol.29, no.1, pp.99-101.

@article{article, author={Sema Buyukkapu Bay Et Al. }, title={Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency}, journal={MELANOMA RESEARCH}, year=2019, pages={99-101} }